160 related articles for article (PubMed ID: 14627350)
1. Helicobacter-independent, chemotherapy-resistant, radiosensitive gastric MALT lymphoma with massive deposits of amyloidlike substance.
Matsumoto H; Koga H; Iida M; Suekane H; Tarumi K; Hoshika K; Mikami Y; Haruma K
Dig Dis Sci; 2003 Oct; 48(10):2018-22. PubMed ID: 14627350
[No Abstract] [Full Text] [Related]
2. Treatment for gastric mucosa-associated lymphoid tissue (MALT) lymphoma.
Maeda T; Niitsu N
Intern Med; 2006; 45(6):353-4. PubMed ID: 16617183
[No Abstract] [Full Text] [Related]
3. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.
Asano N; Iijima K; Koike T; Imatani A; Shimosegawa T
World J Gastroenterol; 2015 Jul; 21(26):8014-20. PubMed ID: 26185372
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori infection and gastric MALTomas: an up-to-date and therapy highlight.
Santacroce L; Cagiano R; Del Prete R; Bottalico L; Sabatini R; Carlaio RG; Prejbeanu R; Vermesan H; Dragulescu SI; Vermesan D; Motoc A; Losacco T
Clin Ter; 2008; 159(6):457-62. PubMed ID: 19169609
[TBL] [Abstract][Full Text] [Related]
5. Treatment Strategy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
Nakamura S; Matsumoto T
Gastroenterol Clin North Am; 2015 Sep; 44(3):649-60. PubMed ID: 26314674
[TBL] [Abstract][Full Text] [Related]
6. [Gastric MALT lymphoma - a case report].
Zálabská E; Bareková L; Klobučar D; Hanovcová I
Klin Mikrobiol Infekc Lek; 2011 Jun; 17(3):89-91. PubMed ID: 21780027
[TBL] [Abstract][Full Text] [Related]
7. [Use of vitaflor to eradicate Helicobacter pylori in treatment of MALT-lymphoma of the stomach].
Gershanovich ML; Petrov LN; Dobritsa VP; Kalinovskiĭ VP; Nikitina MV
Vopr Onkol; 2006; 52(6):696-8. PubMed ID: 17338252
[No Abstract] [Full Text] [Related]
8. Helicobacter pylori associated gastric B cell MALT lymphoma: predictive factors for regression.
Morgner A; Bayerdörffer E; Neubauer A; Stolte M
Gut; 2001 Mar; 48(3):290-2. PubMed ID: 11171813
[No Abstract] [Full Text] [Related]
9. Outcome of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy.
Sugimoto M; Kajimura M; Shirai N; Furuta T; Kanaoka S; Ikuma M; Sato Y; Hishida A
Intern Med; 2006; 45(6):405-9. PubMed ID: 16617193
[TBL] [Abstract][Full Text] [Related]
10. Rectal MALT lymphoma regression and anti-Helicobacter pylori therapy.
Ito Y; Ureshino H; Tsuruoka N; Noda T
QJM; 2018 Oct; 111(10):737-738. PubMed ID: 29961825
[No Abstract] [Full Text] [Related]
11. EUS in MALT lymphoma.
Caletti G; Fusaroli P; Togliani T
Gastrointest Endosc; 2002 Oct; 56(4 Suppl):S21-6. PubMed ID: 12297744
[No Abstract] [Full Text] [Related]
12. [Gastric MALT lymphoma, clinical features].
Udvardy M
Orv Hetil; 1999 Feb; 140(6):291-4. PubMed ID: 10071508
[TBL] [Abstract][Full Text] [Related]
13. Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy.
Caletti G; Togliani T; Fusaroli P; Sabattini E; Khodadadian E; Gamberi B; Gobbi M; Pileri S
Gastroenterology; 2003 Feb; 124(2):537-43. PubMed ID: 12557157
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori strikes again: gastric mucosa-associated lymphoid tissue (MALT) lymphoma.
Swisher SC; Barbati AJ
Gastroenterol Nurs; 2007; 30(5):348-54; quiz 355-6. PubMed ID: 18049205
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori eradication therapy in primary high-grade gastric MALT lymphoma.
Fischbach W
Gastroenterology; 2002 Jul; 123(1):393. PubMed ID: 12105882
[No Abstract] [Full Text] [Related]
16. Metachronous gastric MALT lymphoma and early gastric cancer: a case report.
Seo DB; Kwon KS; Park HS; Lee DH; Kim HG; Shin YW; Kim YS; Kim JM
Korean J Gastroenterol; 2007 Apr; 49(4):245-50. PubMed ID: 17464170
[TBL] [Abstract][Full Text] [Related]
17. Treatment of gastric MALT lymphoma by Helicobacter pylori eradication: a study controlled by endoscopic ultrasonography.
Nobre-Leitão C; Lage P; Cravo M; Cabeçadas J; Chaves P; Alberto-Santos A; Correia J; Soares J; Costa-Mira F
Am J Gastroenterol; 1998 May; 93(5):732-6. PubMed ID: 9625118
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
[TBL] [Abstract][Full Text] [Related]
19. [Radiotherapy for localized gastric and orbital MALT lymphomas].
Quéro L; Hennequin C; Amorim S; Guillerm S; Ruskoné-Fourmestraux A; Thieblemont C
Cancer Radiother; 2016 Oct; 20(6-7):543-6. PubMed ID: 27614509
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.
Chen LT; Lin JT; Shyu RY; Jan CM; Chen CL; Chiang IP; Liu SM; Su IJ; Cheng AL
J Clin Oncol; 2001 Nov; 19(22):4245-51. PubMed ID: 11709568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]